RATIONALITY OF ANTIBIOTICS PRESCRIBING IN COMMUNITYACQUIRED PNEUMONIA PATIENTS AT UNS HOSPITAL INPATIENTS UNIT IN 2021-2022

Abstrak

Community-acquired pneumonia (CAP) is the 3rd largest lower respiratory tract infection that causes death in the world. Treatment therapy that is generally used to treat pneumonia is by administering antibiotics. Irrational use of antibiotics can lead to less effective treatment, decreased drug safety, and increased resistance. This study aims to evaluate the rationality of using antibiotics in community-acquired pneumonia patients at UNS Hospital using the Gyssens method in 2021-2022. This research is a non-experimental research with a descriptive design and purposive sampling technique. Data collection was carried out retrospectively with a sample size of 19 patients who were hospitalized in 2021-2022. The data obtained were analyzed descriptively with the Gyssens assessment. The references used are Regulation of the Minister of Health Republic Indonesia Number 28, 2021 concerning Guidelines for the Use of Antibiotics, Guidelines for the Diagnosis of Community Pneumonia and Its Management in Indonesia 2014, UNS Hospital Drug Formulary, NICE Public Health Guidance 2022, and Dipiro 2020. The results of this study showed that 90.47% of patients received rational antibiotic therapy and 9.53% received irrational antibiotic therapy. Rational antibiotic therapy is an antibiotic that is included in category 0. The irrational use of antibiotics in this study is an antibiotic that is included in the IVC category (there are cheaper alternative antibiotics).